Saudi Arabia

This partnership aims to enhance public health services, raise awareness, and improve disease management through innovative healthcare solutions aligned with Saudi Arabia’s Vision 2030.

This annual ranking, developed in partnership with the global data analytics firm Statista, highlights hospitals that excel in delivering advanced, high-quality care and enhancing patient experiences worldwide.

The partnership is designed to bring advanced therapeutic and diagnostic technologies to Saudi Arabia, enhancing the country’s healthcare system and supporting its shift toward a more sustainable, patient-centered model.

By shifting manufacturing to the local level, Novo Nordisk aims to increase access to its life-changing medicines, serve more patients, and simultaneously support the development of local industry and workforce skills.

Cochlear implants are sophisticated medical devices that restore hearing to individuals with severe hearing loss by bypassing damaged parts of the inner ear.

This innovative procedure involves inserting a next-generation bioresorbable stent through a fine catheter inserted in the thigh, which avoids the need for open surgery.

The program, known as “Bupa No Pre-Approvals,” allows insured individuals to receive medical treatment immediately at select hospitals, without the usual requirement for prior authorization.

The Magnet Recognition Program highlights healthcare organizations that demonstrate exceptional patient care, nursing leadership, and innovative practices in professional nursing.

Reporting directly to Mohamed Alshamari, CEO of Aster Hospitals & Clinics in Saudi Arabia, Prof. Turki will oversee hospital strategy, optimize patient care, and expand services while maintaining high standards of healthcare delivery.